MTOR and neoplasm: Measurement of the phosphorylation status of ph-p70S6K1 and ph-4EBP1 in the tumor itself, confirmed that everolimus resulted in a downregulation of mTOR downstream effectors, whereas doxorubicin had no effect on its phosphorylation status.